Fecal transplant program for active ulcerative colitis donors
Treatments studied
Part of Digestive system clinical trials.
This trial screens people as potential donors for a fecal microbiota transplant program used for ulcerative colitis. It checks safety and eligibility so the transplant process is as safe as possible for people with active disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (age 18 or older)
- Have active ulcerative colitis symptoms based on specific Mayo score cutoffs
- Have endoscopic (colonoscopy) findings showing active disease
- If you can get pregnant, agree to reliable birth control during the study
- Do not join another ulcerative colitis treatment study at the same time
- Avoid recent antibiotic use (within the last 30 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This trial tests fecal microbiota transplantation (a procedure that puts healthy donor bacteria into your gut) for left-sided ulcerative colitis. It compares results using donors from two different backgrounds to see if one works better.
This trial tests whether transplanting stool bacteria (called fecal microbiota transplantation, or FMT) can improve symptoms in people with active ulcerative colitis. You may be able to help test a new approach for restoring gut bacteria, while receiving standard ulcerative colitis care from your doctor.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
This early-stage study tests whether a one-time transfer of “donor gut bacteria” can improve ulcerative colitis. It’s designed for people with mild to moderate ulcerative colitis who are stable on maintenance treatment.
This trial tests whether giving children with ulcerative colitis a transplant of healthy donor stool (fecal microbiota transplant) can help control their disease. It aims to see if this treatment can reduce inflammation in the gut.
Hear when a new Ulcerative Colitis Flare trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.